Logo

RxP and BioTrove Ink SNP, Gene-Expression Deal

Jan 30, 2006

NEW YORK, Jan. 30 (GenomeWeb News) - BioTrove and RxGen PrimaTox are working jointly to provide gene expression and SNP assays for primates and humans, BioTrove said today.

Under the deal, RxP will provide its tox-optimum assays exclusively to BioTrove, either as stand-alone products or as a service. BioTrove will manufacture the assays to RxP's specifications, using its OpenArray platform.

Financial details were not disclosed.

As GenomeWeb News reported last week, RxGen PrimaTox is a wholly owned subsidiary of RxGen focused on drug-safety products and services. It is also building a primate-based molecular toxicology database to be available on a subscription basis.

Breaking News
The Scan

Myotonic Dystrophy Repeat Detected in Family Genome Sequencing Analysis

While sequencing individuals from a multi-generation family, researchers identified a myotonic dystrophy type 2-related short tandem repeat in the European Journal of Human Genetics.

TB Resistance Insights Gleaned From Genome Sequence, Antimicrobial Response Assays

Researchers in PLOS Biology explore M. tuberculosis resistance with a combination of sequencing and assays looking at the minimum inhibitory concentrations of 13 drugs.

Mendelian Disease Genes Prioritized Using Tissue-Specific Expression Clues

Mendelian gene candidates could be flagged for further functional analyses based on tissue-specific transcriptome and proteome profiles, a new Journal of Human Genetics paper says.

Single-Cell Sequencing Points to Embryo Mosaicism

Mosaicism may affect preimplantation genetic tests for aneuploidy, a single-cell sequencing-based analysis of almost three dozen embryos in PLOS Genetics finds.